150 related articles for article (PubMed ID: 31362708)
1. Exceptional response to chemotherapy followed by concurrent radiotherapy and immunotherapy in a male with primary retroperitoneal serous Adenocarcinoma: a case report and literature review.
Chae YK; Saleem N; Roh Y; Bilal H; Viveiros P; Sukhadia B; Lin X; Sheikh MM; Park LC
BMC Cancer; 2019 Jul; 19(1):748. PubMed ID: 31362708
[TBL] [Abstract][Full Text] [Related]
2. A case of primary retroperitoneal serous adenocarcinoma.
Arichi N; Yasumoto H; Mitsui Y; Hiraoka T; Honda S; Shiina H; Igawa M
Int J Urol; 2011 Dec; 18(12):844-6. PubMed ID: 21992013
[TBL] [Abstract][Full Text] [Related]
3. Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone.
Afzal MZ; Mabaera R; Shirai K
J Immunother Cancer; 2018 Feb; 6(1):13. PubMed ID: 29433557
[TBL] [Abstract][Full Text] [Related]
4. Nivolumab and its use in the second-line treatment of metastatic urothelial cancer.
Raggi D; Necchi A; Giannatempo P
Future Oncol; 2018 Nov; 14(26):2683-2690. PubMed ID: 29927336
[TBL] [Abstract][Full Text] [Related]
5. A primary retroperitoneal serous cystadenocarcinoma with clinically aggressive behavior.
Kaku M; Ohara N; Seima Y; Imanishi K; Tomura N; Kobayashi A; Yamasaki M; Hirata Y; Murao S
Arch Gynecol Obstet; 2004 Dec; 270(4):302-6. PubMed ID: 14551796
[TBL] [Abstract][Full Text] [Related]
6. Resection for Primary Retroperitoneal Serous Adenocarcinoma and Liver Metastasis.
Nakatake R; Ishizaki M; Ishida M; Matsui K; Kawaguchi Y; Kaibori M
Intern Med; 2018 Dec; 57(23):3371-3375. PubMed ID: 30101904
[TBL] [Abstract][Full Text] [Related]
7. Anti-PD-1 immunotherapy in combination with sequential involved-site radiotherapy in heavily pretreated refractory Hodgkin lymphoma.
Quéro L; Gilardin L; Fumagalli I; Martin V; Guillerm S; Bauduceau O; Kirova YM; Hennequin C; Brice P
Cancer Radiother; 2019 Apr; 23(2):132-137. PubMed ID: 30733172
[TBL] [Abstract][Full Text] [Related]
8. Added value of contrast-enhanced ultrasound (CEUS) in the diagnosis of primary retroperitoneal serous adenocarcinoma: a case report.
Zhou LY; Zhu XD; Jiang J; Bai YF; Jiang TA
BMC Med Imaging; 2021 May; 21(1):80. PubMed ID: 33980163
[TBL] [Abstract][Full Text] [Related]
9. Primary malignant melanoma of the esophagus, treated with immunotherapy: a case report.
Rochefort P; Roussel J; de la Fouchardière A; Sarabi M; Desseigne F; Guibert P; Cattey-Javouhey A; Mastier C; Neidhardt-Berard EM; de la Fouchardière C
Immunotherapy; 2018 Aug; 10(10):831-835. PubMed ID: 30073896
[TBL] [Abstract][Full Text] [Related]
10. Nivolumab in the treatment of microsatellite instability high metastatic colorectal cancer.
Mehrvarz Sarshekeh A; Overman MJ; Kopetz S
Future Oncol; 2018 Aug; 14(18):1869-1874. PubMed ID: 29473436
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Chemotherapy Following Anti-PD-1 Antibody Therapy for Gastric Cancer: A Case of Sclerosing Cholangitis.
Kono M; Sakurai T; Okamoto K; Masaki S; Nagai T; Komeda Y; Kamata K; Minaga K; Yamao K; Takenaka M; Watanabe T; Nishida N; Kudo M
Intern Med; 2019 May; 58(9):1263-1266. PubMed ID: 30626829
[TBL] [Abstract][Full Text] [Related]
12. A man with recurrent hypovolemic shock on anti-programmed cell death protein 1 treatment: Immune-related protein-losing enteropathy.
Lee SY; Kim MH; Jang M; Park Y; Cho BC
Eur J Cancer; 2018 Nov; 104():104-107. PubMed ID: 30342309
[No Abstract] [Full Text] [Related]
13. There and back again: An immunotherapy tale.
Guo Y; Krupnick AS
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1771-1774. PubMed ID: 29409610
[No Abstract] [Full Text] [Related]
14. Clinical implications of monitoring nivolumab immunokinetics in non-small cell lung cancer patients.
Osa A; Uenami T; Koyama S; Fujimoto K; Okuzaki D; Takimoto T; Hirata H; Yano Y; Yokota S; Kinehara Y; Naito Y; Otsuka T; Kanazu M; Kuroyama M; Hamaguchi M; Koba T; Futami Y; Ishijima M; Suga Y; Akazawa Y; Machiyama H; Iwahori K; Takamatsu H; Nagatomo I; Takeda Y; Kida H; Akbay EA; Hammerman PS; Wong KK; Dranoff G; Mori M; Kijima T; Kumanogoh A
JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282824
[TBL] [Abstract][Full Text] [Related]
15. Long-term control and partial remission after initial pseudoprogression of glioblastoma by anti-PD-1 treatment with nivolumab.
Roth P; Valavanis A; Weller M
Neuro Oncol; 2017 Mar; 19(3):454-456. PubMed ID: 28039369
[No Abstract] [Full Text] [Related]
16. Adjuvant Pelvic Radiation "Sandwiched" Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a Prospective Phase 2 Trial.
Frimer M; Miller EM; Shankar V; Girda E; Mehta K; Smith HO; Kuo DYS; Goldberg GL; Einstein MH
Int J Gynecol Cancer; 2018 Nov; 28(9):1781-1788. PubMed ID: 30371562
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy With Programmed Cell Death 1 Inhibitors for 5 Patients With Conjunctival Melanoma.
Sagiv O; Thakar SD; Kandl TJ; Ford J; Sniegowski MC; Hwu WJ; Esmaeli B
JAMA Ophthalmol; 2018 Nov; 136(11):1236-1241. PubMed ID: 30352118
[TBL] [Abstract][Full Text] [Related]
18. Response to PD1 inhibition in conventional chondrosarcoma.
Wagner MJ; Ricciotti RW; Mantilla J; Loggers ET; Pollack SM; Cranmer LD
J Immunother Cancer; 2018 Sep; 6(1):94. PubMed ID: 30253794
[TBL] [Abstract][Full Text] [Related]
19. Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report.
Merhi M; Raza A; Inchakalody VP; Nashwan AJJ; Allahverdi N; Krishnankutty R; Uddin S; Zar Gul AR; Al Homsi MU; Dermime S
Front Immunol; 2018; 9():1769. PubMed ID: 30108590
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy.
Finazzi T; Rordorf T; Ikenberg K; Huber GF; Guckenberger M; Garcia Schueler HI
BMC Cancer; 2018 Apr; 18(1):395. PubMed ID: 29625593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]